Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Jan-24 11:45 AM View:  | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 12-Jan-24 | Private Purchase | 1,000 | $6.50 | $6,500.00 | < 1% 197.63K to 198.63K | |
| 12-Jan-24 12:47 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 11-Jan-24 | Private Purchase | 2,000 | $6.27 | $12,540.00 | 1% 195.63K to 197.63K | |
| 11-Jan-24 10:57 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 10-Jan-24 | Private Purchase | 2,944 | $6.31 | $18,576.60 | 2% 192.68K to 195.63K | |
| 10-Jan-24 8:57 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 09-Jan-24 | Private Purchase | 3,000 | $6.25 | $18,750.00 | 2% 189.68K to 192.68K | |
| 09-Jan-24 9:08 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 08-Jan-24 | Private Purchase | 1,000 | $6.15 | $6,150.00 | < 1% 188.68K to 189.68K | |
| 08-Jan-24 3:11 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 05-Jan-24 | Private Purchase | 2,000 | $6.09 | $12,180.00 | 1% 186.68K to 188.68K | |
| 08-Jan-24 2:54 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 04-Jan-24 | Private Purchase | 3,000 | $6.12 | $18,360.00 | 2% 183.68K to 186.68K | |
| 04-Jan-24 1:37 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 03-Jan-24 | Private Purchase | 500 | $5.83 | $2,915.00 | < 1% 183.18K to 183.68K | |
| 26-Dec-23 11:48 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 21-Dec-23 | Private Purchase | 2,500 | $4.92 | $12,300.00 | 1% 180.68K to 183.18K | |
| 21-Dec-23 2:31 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 20-Dec-23 | Private Purchase | 2,100 | $4.82 | $10,122.00 | 1% 178.58K to 180.68K | |
| 20-Dec-23 9:48 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 19-Dec-23 | Private Purchase | 5,000 | $4.75 | $23,750.00 | 3% 173.58K to 178.58K | |
| 05-Jan-24 3:52 PM View: | Ackerman Joel Director | Champions Biotechnology, Inc. (CSBR) | 17-Oct-23 | Option Exercise | 114,552 | $2.10 | $240,559.00 | 15% 742.45K to 857.0K | |
| 13-Oct-23 12:48 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 11-Oct-23 | Private Purchase | 5,000 | $6.40 | $32,000.00 | 3% 158.08K to 163.08K | |
| 11-Oct-23 9:45 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 10-Oct-23 | Private Purchase | 1,100 | $6.41 | $7,051.00 | < 1% 156.98K to 158.08K | |
| 10-Oct-23 10:02 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 06-Oct-23 | Private Purchase | 1,530 | $6.48 | $9,914.40 | < 1% 155.45K to 156.98K | |
| 06-Oct-23 7:10 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 05-Oct-23 | Private Purchase | 2,000 | $6.47 | $12,940.00 | 1% 153.45K to 155.45K | |
| 04-Oct-23 5:30 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 04-Oct-23 | Private Purchase | 5,000 | $6.40 | $32,000.00 | 3% 148.45K to 153.45K | |
| 04-Oct-23 5:31 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 03-Oct-23 | Private Purchase | 2,500 | $6.30 | $15,750.00 | 2% 145.95K to 148.45K | |
| 16-Oct-23 9:53 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 29-Sep-23 | Private Purchase | 4,000 | $6.16 | $24,640.00 | 2% 169.58K to 173.58K | |
| 16-Oct-23 9:52 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 28-Sep-23 | Private Purchase | 5,000 | $6.22 | $31,100.00 | 3% 164.58K to 169.58K | |
| 16-Oct-23 9:51 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 27-Sep-23 | Private Purchase | 1,500 | $5.95 | $8,925.00 | < 1% 163.08K to 164.58K | |
| 27-Sep-23 9:56 AM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 26-Sep-23 | Private Purchase | 5,000 | $5.65 | $28,250.00 | 4% 140.95K to 145.95K | |
| 25-Sep-23 2:59 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 22-Sep-23 | Private Purchase | 3,812 | $5.50 | $20,966.00 | 3% 137.14K to 140.95K | |
| 25-Sep-23 2:59 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 21-Sep-23 | Private Purchase | 5,000 | $5.51 | $27,550.00 | 4% 132.14K to 137.14K | |
| 25-Sep-23 2:59 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 20-Sep-23 | Private Purchase | 4,018 | $5.51 | $22,139.20 | 3% 128.12K to 132.14K | |
| 25-Sep-23 3:00 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 19-Sep-23 | Private Purchase | 5,000 | $5.28 | $26,400.00 | 4% 123.12K to 128.12K | |
| 21-Mar-23 12:30 PM View: | Morris Ronnie CEO Director | Champions Biotechnology, Inc. (CSBR) | 17-Mar-23 | Private Purchase | 12,382 | $4.04 | $49,968.80 | 1% 846.5K to 858.88K | |
| 20-Oct-22 1:26 PM View: | Ackerman Joel Director | Champions Biotechnology, Inc. (CSBR) | 19-Oct-22 | Option Exercise | 16,667 | $3.21 | $53,501.10 | 1% 1.44M to 1.46M | |
| 13-Oct-22 9:00 AM View: | Tobin Scott R Director | Champions Biotechnology, Inc. (CSBR) | 12-Oct-22 | Option Exercise | 10,000 | $3.21 | $32,100.00 | 50% 20.0K to 30.0K | |
| 14-Oct-22 2:27 PM View: | Sidransky David Director | Champions Biotechnology, Inc. (CSBR) | 12-Oct-22 | Option Exercise | 8,333 | $3.21 | $26,748.90 | 1% 762.27K to 770.61K | |
| 14-Oct-22 2:25 PM View: | Breitfeld Philip P. Director | Champions Biotechnology, Inc. (CSBR) | 12-Oct-22 | Payment of Exercise | 3,562 | $7.51 | $26,750.60 | (20%) 18.2K to 14.64K | |
| 14-Oct-22 2:25 PM View: | Breitfeld Philip P. Director | Champions Biotechnology, Inc. (CSBR) | 12-Oct-22 | Option Exercise | 8,333 | $3.21 | $26,748.90 | 84% 9.87K to 18.2K | |
| 14-Oct-22 2:27 PM View: | Sidransky David Director | Champions Biotechnology, Inc. (CSBR) | 12-Oct-22 | Payment of Exercise | 3,562 | $7.51 | $26,750.60 | (< 1%) 770.61K to 767.04K | |
| 19-Oct-21 3:39 PM View: | Sidransky David Director | Champions Biotechnology, Inc. (CSBR) | 15-Oct-21 | Option Exercise | 16,667 | $1.59 | $26,500.50 | 2% 745.61K to 762.27K | |
| 19-Oct-21 3:39 PM View: | Sidransky David Director | Champions Biotechnology, Inc. (CSBR) | 15-Oct-21 | Payment of Exercise | 2,629 | $10.08 | $26,500.30 | < 1% 742.98K to 745.61K | < 1% |
| 13-Oct-21 10:26 AM View: | Tobin Scott R Director | Champions Biotechnology, Inc. (CSBR) | 12-Oct-21 | Option Exercise | 10,000 | $1.59 | $15,900.00 | 100% 10.0K to 20.0K | |
| 25-Mar-21 3:27 PM View: | Breitfeld Philip P. Director | Champions Biotechnology, Inc. (CSBR) | 23-Mar-21 | Payment of Exercise | 1,340 | $11.35 | $15,209.00 | (32%) 4.17K to 2.83K | |
| 25-Mar-21 3:27 PM View: | Breitfeld Philip P. Director | Champions Biotechnology, Inc. (CSBR) | 23-Mar-21 | Option Exercise | 4,167 | $3.65 | $15,209.60 | 100% 0 to 4.17K | |
| 08-Feb-21 4:46 PM View: | Poliakoff Abba David Director | Champions Biotechnology, Inc. (CSBR) | 19-Jan-21 | Option Exercise | 30,000 | $3.41 | $102,300.00 | 59% 51.27K to 81.27K | |
| 08-Feb-21 4:46 PM View: | Poliakoff Abba David Director | Champions Biotechnology, Inc. (CSBR) | 19-Jan-21 | Payment of Exercise | 8,873 | $11.53 | $102,306.00 | 21% 42.4K to 51.27K | (6%) |
| 17-Dec-20 9:29 AM View: | Breitfeld Philip P. Director | Champions Biotechnology, Inc. (CSBR) | 16-Dec-20 | Market Sale | 31,443 | $11.35 | $356,976.00 | (100%) 31.44K to 0 | 3% |
| 30-Oct-20 4:36 PM View: | Tobin Scott R Director | Champions Biotechnology, Inc. (CSBR) | 30-Oct-20 | Option Exercise | 10,000 | $5.46 | $54,600.00 | 100% 0 to 10.0K | |
| 28-Oct-20 2:53 PM View: | Sidransky David Director | Champions Biotechnology, Inc. (CSBR) | 16-Oct-20 | Option Exercise | 16,667 | $5.46 | $91,001.80 | 2% 741.67K to 758.33K | |
| 28-Oct-20 2:53 PM View: | Sidransky David Director | Champions Biotechnology, Inc. (CSBR) | 16-Oct-20 | Payment of Exercise | 10,100 | $9.01 | $91,001.00 | (1%) 758.33K to 748.23K | (23%) |
| 30-Mar-20 4:56 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 26-Mar-20 | Market Purchase | 1,220 | $5.91 | $7,213.00 | 2% 57.53K to 58.75K | 87% |
| 26-Mar-20 3:00 PM View: | Mendelson Daniel Newman Director | Champions Biotechnology, Inc. (CSBR) | 24-Mar-20 | Market Purchase | 26 | $5.50 | $143.00 | < 1% 57.5K to 57.53K | 101% |
| 26-Mar-20 2:52 PM View: | Morris Ronnie CEO Director | Champions Biotechnology, Inc. (CSBR) | 24-Mar-20 | Market Sale | 75 | $5.25 | $393.75 | (< 1%) 837.24K to 837.17K | (110%) |
| 24-Mar-20 9:54 AM View: | Morris Ronnie CEO Director | Champions Biotechnology, Inc. (CSBR) | 20-Mar-20 | Market Purchase | 75 | $4.75 | $356.25 | < 1% 837.17K to 837.24K | 132% |
| 12-Mar-20 2:03 PM View: | Battery Ventures Ix, L.P. 10% Owner | Champions Biotechnology, Inc. (CSBR) | 11-Mar-20 | Exercise (in-the money or at-the-money) | 409,791 | $5.47 | $2,242,000.00 | 20% 2.01M to 2.42M | 102% |
| 03-Nov-20 5:38 PM View: | Morris Ronnie CEO Director | Champions Biotechnology, Inc. (CSBR) | 11-Mar-20 | Option Exercise | 126,940 | $5.74 | $728,575.00 | 15% 837.17K to 964.11K | 92% |
